Murine Irritation & Redness Relief (Naphazoline Hydrochloride)

Naphazoline is a selective alpha‑adrenergic agonist. When applied to the eye, it binds to alpha‑receptors on the smooth muscle of conjunctival vessels, causing them to contract. This vasoconstriction reduces blood flow to the ocular surface, which diminishes redness and swelling associated with minor irritation.

The appropriate dose and frequency are determined by the prescribing clinician. Typically, one drop is placed in the affected eye(s) as needed, not exceeding the maximum daily frequency recommended on the product label, and use should not be prolonged beyond a few days without medical advice.

Safety data for naphazoline in pregnancy and lactation are limited. The product should be used only if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Naphazoline is comparable to other topical decongestants such as tetrahydrozoline or phenylephrine. All act by vasoconstriction, but naphazoline has a rapid onset and a relatively short duration of action. Choice of agent often depends on clinician preference, patient tolerance, and specific formulation characteristics.

Store the eye‑drop solution at ambient temperature, preferably below 25 °C, in its original container. Protect it from moisture, direct sunlight, and extreme temperature fluctuations. Keep the cap tightly closed when not in use to maintain sterility.

The product is applied topically as an eye drop. After washing hands, tilt the head back, pull down the lower eyelid to create a small pocket, and place one drop into the conjunctival sac. Close the eye gently for a few seconds to allow distribution, then avoid touching the dropper tip to any surface.

Serious adverse events, though rare, include severe allergic reactions (e.g., eyelid swelling, rash), marked eye pain, sudden vision loss, and systemic hypertension. If any of these occur, discontinue use immediately and seek medical attention.

Individuals with known hypersensitivity to naphazoline or any component of the formulation should avoid the product. It is also contraindicated in patients with severe ocular conditions such as acute angle‑closure glaucoma, uncontrolled hypertension, or those who have recently undergone ocular surgery without physician approval.